• Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources

    4 days ago - By Reuters

    Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday.
    Read more ...

     

  • Exclusive: EU regulators to clear $62 billion Takeda, Shire deal - source

    4 days ago - By Reuters

    EU antitrust regulators are set to approve Japanese drugmaker Takeda Pharmaceutical's $62-billion offer for London peer Shire on condition that Shire sells a drug it has in development, a person familiar with the matter said on Friday.
    Read more ...